Form 4: Definitive Healthcare CEO Kevin Coop Acquires Restricted Stock and Performance-Based Stock Units

CEO Kevin Coop reports acquisition of restricted stock units and performance-based stock units in Definitive Healthcare Corp.

Summary

• Kevin Coop, CEO of Definitive Healthcare Corp., filed a Form 4 disclosing changes in beneficial ownership.
• The report details the acquisition of 1,170,047 Class A Common Stock restricted stock units (RSUs) and 1,137,038 performance-based stock units (PSUs) on June 24, 2024.
• The RSUs vest 25% on July 1, 2025, and then 6.25% every three months over the subsequent three years, contingent upon continued service.
• The PSUs vest in four tranches based on stock price hurdles and continued service, with performance periods of two and four years.
• The stock price hurdles for the PSUs range from $10.00 to $27.00, requiring the average closing price of Class A Common Stock to be at least that amount for 30 consecutive trading days during the applicable performance period.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of RSUs and PSUs is a standard practice, but the performance-based vesting of PSUs suggests confidence in the company's future performance.

Positives

• The vesting of PSUs is tied to stock price performance, aligning management's interests with those of shareholders.
• The vesting schedule of the RSUs encourages long-term commitment from the CEO.

Risks

• The vesting of PSUs is contingent on achieving specific stock price targets, which may not be met.
• The value of the RSUs and PSUs is dependent on the future performance of the company's stock.

Future Outlook

The vesting of the PSUs is dependent on the company's stock price reaching certain hurdles over the next four years, indicating an expectation of future growth.

Industry Context

Equity compensation is a common practice in the healthcare technology industry to attract and retain top talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors.
• Companies like Veeva Systems and Teladoc Health also utilize RSUs and PSUs as part of their executive compensation packages.
• The specific vesting schedules and performance metrics vary depending on the company's size, growth stage, and strategic objectives.

Stakeholder Impact

• Shareholders may view the performance-based compensation positively, as it aligns management's interests with stock price appreciation.
• Employees may be motivated by the company's growth prospects, which are tied to the vesting of the PSUs.

Key Dates